|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2007)) |
IUPAC Name ![]() |
| (2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7992 | aliskiren |
Synonyms ![]() |
| CGP-060536B |
| SPP100 |
| Tekturna® |
Database Links ![]() |
|
| CAS Registry No. | 173334-57-1 (source: Scifinder) |
| ChEBI | CHEBI:601027 |
| ChEMBL Ligand | CHEMBL1639 |
| DrugBank Ligand | DB01258 |
| PubChem CID | 5493444 |
| RCSB PDB Ligand | C41 |
| Search Google for chemical match using the InChIKey | UXOWGYHJODZGMF-QORCZRPOSA-N |
| Search Google for chemicals with the same backbone | UXOWGYHJODZGMF |
| Search PubMed clinical trials | aliskiren |
| Search PubMed titles | aliskiren |
| Search PubMed titles/abstracts | aliskiren |
| Wikipedia | Aliskiren |
| Comments |
| Aliskiren is the first in class renin inhibitor. The Tekturna trade name refers to the hemi-fumarate: (PubChem CID 6918427). Ligand structure in PDB (see link) |